Auto-generated from public data. Not the firm's stated position.
4See Ventures appears to focus on early-stage deep-tech companies in the cleantech and life sciences sectors, deploying €1.5M–€3.0M checks at pre-seed and seed stages. Based on disclosed portfolio data, the firm backs companies developing transformative technologies across nuclear energy, RNA therapeutics, and surgical robotics, suggesting an investment thesis centered on science-driven solutions to significant global challenges.
Generated 7 Aug 2026 from disclosed sectors, stages, and portfolio companies. Firms can update this by emailing [email protected].
€1.5M – €3M
Auto-extracted from press releases.
Website reachable as of Sept 2026. Focus and check size as listed by the firm, not independently verified.
Learn what 4See Ventures and similar investors look for:
Cleantech pitch guideTips, programs, and cultural notes
A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.